股市资讯 | 美股延续年初强势,标普指数站上2800关口

wechat omage

美股

北京时间3月2日凌晨,美股周五收高,延续了近30年来的最强年初涨势。标普500指数自11月以来首次收在2800关口上方。

截至收盘,道指涨110.32点,或0.43%,报26026.32点;标普500指数涨19.20点,或0.69%,报2803.69点;纳指涨62.82点,或0.83%,报7595.35点。

标普500指数当中,医疗保健与能源板块涨幅领先。亚马逊领涨纳指。

周五之前,美股在2月份录得较大涨幅,使标普500指数收获1991年以来的最强年初开局涨势。截至2月28日收盘,标普500指数在今年前两个月累计涨幅高达11%,而道指与纳指的涨幅均超过14%。

宏观基本面:

美国经济数据备受关注。美国商务部周五报告称,美国1月份的个人收入环比下降0.1%,而预期为增长0.3%。12月个人收入增长1%,是6年来的最大增幅。这份报告表明1月份美国的个人收入出人意料地下降,这是大约三年来的首次下降。12月份美国个人收入大涨的原因是特殊股息和农业补贴。

该数据还显示美国12月个人消费支出(PCE)环比下降0.5%,预期下降0.3%,前值为增长 0.4%。剔除一些特殊项目后,1月份工资和薪金继续稳步增长,环比增长0.3%,增幅为0.5%。

12月主要PCE物价指数较上年同期上涨1.7%,11月为1.8%。按月计,该指数上升0.1%,高于预估,且核心指数上升0.2%,符合预期。去年12月份的个人储蓄率从上个月的6.1%跃升至7.6%,为2016年以来的最高水平。

美国2月美国密歇根大学消费者信心指数下降至93.8,而接受MarketWatch调查的经济学家平均预期值为95.6。

2月ISM制造业调查指数从56.6下降至54.2,显示美国制造业增长速度已下降至2016年11月特朗普上台以来的最低值。

周四公布的美国国内生产总值(GDP)数据显示第四季度经济增长率放缓至2.6%,超出接受MarketWatch调查的经济学家所平均预期的1.9%。

焦点股关注:

服装零售业巨头Gap(GPS)受到关注,该公司在周四收盘后宣布将拆分为两家上市公司,并关闭大约200家店面。

体育用品与服装零售商Foot Locker(FL)股价攀升,该公司宣布第四财季盈利超出预期。

Immunogen(IMGN)股价大幅下跌,该公司宣布,相对于化疗对照组,其实验性卵巢癌治疗药物mirvetuximab soravtansine在第三期未能达到使患者生存并且病情不恶化的主要目标。

特斯拉股价走低,该公司CEO马斯克警告称公司第一季度可能无法实现盈利。

 

   

港股

北京时间3月1日,美股周四小幅收跌,但三大股指2月表现强劲。特金会无果而终。美第四季度GDP超出预期。首请失业救济数据显示美国劳动力市场仍然强劲。周五开盘,港股恒生指数高开0.29%,随后在28770点上下波动。

截止收盘,恒指涨0.63%,报28812.17点;国企指数涨1.23%,报11506.94点;红筹指数涨1.83%,报4539.04点。

沪港通资金流向方面,沪股通净流入12.57亿,港股通(沪)净流入为0.92亿。

深港通资金流向方面,深股通净流入21.56亿,港股通(深)净流入为8.15亿。

热点板块:

中资金融股集体上涨。中国银河涨6.74%;广发证券涨4.53%;新华保险涨6.05%;中国人寿涨5.56%领涨蓝筹;招商银行涨3.47%。

内房股上涨。中国奥园涨10.37%;雅居乐集团涨4.99%;碧桂园涨3.09%。

平安好医生2018总收入增长78.7%,股价大涨14.85%,报45.25港元。2月27日,平安好医生 公布了上市后的首份年度财报。报告显示,2018年全年,该公司总收入33.38亿元,同比增长78.7%。其中,核心业务家庭医生服务板块营业收入人民币4.11亿元,同比增长 69.6%。同时,受益于AI辅助诊疗系统提升效率,平安好医生全年的日均在线咨询量达到53.5万,同比增长45.4%。

 

 

中国A股

北京时间3月1日,两市周五高开,呈宽幅震荡走势,盘中金融、军工等板块表现活跃,尾盘金融板块再度发力护盘,上证50涨超2%,创本轮反弹新高,三大股指集体涨超1%。

截至收盘,沪指报2994.01点,涨幅1.80%,深成指报9167.65点,涨幅1.50%。

从盘面上看,养鸡、券商、水泥、白酒、海工装备、信托、银行等板块涨幅居前,造纸、网约车、细胞免疫治疗、酒店餐厅等板块跌幅居前。

热点板块:

券商股涨幅居前,国盛金控、中信建投涨停,太平洋、中国银河涨超6%,华林证券、华鑫股份、天风证券、南京证券、第一创业等纷纷涨超4%。

白酒股尾盘拉升,五粮液、山西汾酒涨超6%,今世缘、泸州老窖、贵州茅台、洋河股份、口子窖、伊力特等涨幅居前。
 

如果有想了解更多全球股市资讯,请关注微信公众共 “辉立资本新加坡” (SGPSPL)

同时提供在线免费开设股票账户,一个账户轻松交易美股,港股,新加坡股
 

来源:东方财富网,新浪财经,同花顺,21世纪经济报道,彭博,华尔街见闻,辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com